Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160021/S051

GORE VIABAHN VBX Balloon Expandable Endoprosthesis

W. L. Gore & Associates, Inc. · Decision date Oct 8, 2026

MEDTECHLEDGER EXPLANATIONP160021/S051

What did the FDA approve?

The FDA record lists PMA supplement P160021/S051 for the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis, filed by W. L. Gore & Associates, Inc., with a decision date of 2026-10-08 and decision code APPR. The supplement type is Panel Track, and the reason given is a labeling change covering indications or instructions, shelf life, or tradename. The product code is PRL, described as an iliac covered stent, arterial, in the cardiovascular specialty.

The supplied statement describes the change as expanding the indications to include use as a bridging stent to maintain visceral artery perfusion in fenestrated and branched endovascular aortic aneurysm repair, abbreviated FEVAR and BEVAR. The identifier places this supplement under the original PMA P160021, but the record does not establish a new approval of the whole system. The statement reports the stated purpose of the labeling expansion and does not by itself provide evidence of safety or clinical effectiveness.

FDA approval order statement

expanding the indications to include use as a bridging stent to maintain visceral artery perfusion in fenestrated and branched endovascular aortic aneurysm repair (FEVAR and BEVAR)
Regulatory pathway
PMA supplement
Supplement type
Panel Track
Clinical specialty
Cardiovascular
Decision date
Oct 8, 2026
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P160021/S051
Regulatory pathway
PMA supplement
Product code
PRL
Decision code
APPR
Decision date
Oct 8, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Iliac covered stent, arterial.

Product code
PRL
FDA device class
3

For the original device and its historical approval scope, see PMA P160021. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160021 · Original PMA

    GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS

  2. P160021/S051 received

    Application receipt date recorded by FDA.

  3. P160021/S051 · FDA decision

    Panel Track

Timeline entries are records held by MedtechLedger for P160021. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160021

Product / regulatory recordCompanyPathwayDecision dateSource
W. L. Gore & Associates, Inc.PMA approvalJan 27, 2017FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

W. L. Gore & Associates, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
3250 W. Kiltie Ln., Flagstaff, AZ, 86005

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records